Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here is one stock where Wall Street’s pessimism is creating a buying opportunity and two where the skepticism is well-placed.
Two Stocks to Sell:
Rush Enterprises (RUSHA)
Consensus Price Target: $86.50 (6% implied return)
Headquartered in Texas, Rush Enterprises (NASDAQ: RUSH.A) provides truck-related services and solutions, including sales, leasing, parts, and maintenance for commercial vehicles.
Why Is RUSHA Risky?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 4.3% annually over the last two years
- Earnings per share have dipped by 6.3% annually over the past two years, which is concerning because stock prices follow EPS over the long term
- Waning returns on capital imply its previous profit engines are losing steam
At $81.64 per share, Rush Enterprises trades at 19.8x forward P/E. If you’re considering RUSHA for your portfolio, see our FREE research report to learn more.
ICU Medical (ICUI)
Consensus Price Target: $176.63 (6.1% implied return)
Founded in 1984 and named for its initial focus on intensive care units, ICU Medical (NASDAQ: ICUI) develops and manufactures medical products for infusion therapy, vascular access, and vital care applications used in hospitals and other healthcare settings.
Why Are We Cautious About ICUI?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 1.6% annually over the last two years
- Annual earnings per share growth of 2.9% underperformed its revenue over the last five years, showing its incremental sales were less profitable
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
ICU Medical is trading at $166.46 per share, or 20x forward P/E. To fully understand why you should be careful with ICUI, check out our full research report (it’s free).
One Stock to Watch:
Raymond James (RJF)
Consensus Price Target: $185.92 (6.9% implied return)
Founded in 1962 and headquartered in St. Petersburg, Florida, Raymond James Financial (NYSE: RJF) is a diversified financial services company that provides wealth management, investment banking, asset management, and banking services to individuals and institutions.
Why Does RJF Stand Out?
- Share repurchases have increased shareholder returns as its annual earnings per share growth of 14.1% exceeded its revenue gains over the last five years
- 10% annual tangible book value per share growth over the last two years surpassed the sector average as it leveraged its balance sheet to deliver strong returns
- Stellar return on equity showcases management’s ability to surface highly profitable business ventures
Raymond James’s stock price of $173.93 implies a valuation ratio of 12.9x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
